Financing ·
Crescent Biopharma, Inc. entered into an underwriting agreement with Jefferies LLC and TD Securities (USA) LLC to…
CBIOCrescent Biopharma, Inc.
Crescent Biopharma, Inc. entered into an underwriting agreement with Jefferies LLC and TD Securities (USA) LLC to issue and sell 8,094,793 ordinary shares at $14.50 per share and 525,897 pre-funded warrants at $14.499 per warrant. The company expects to receive net proceeds of approximately $115.9 million, potentially increasing to $133.5 million if the underwriters' option to purchase additional shares is exercised. Crescent Biopharma is a clinical-stage biotechnology company focused on developing oncology therapies for cancer patients.